Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Myr (MYRG) EBITDA (2016 - 2026)

Myr has reported EBITDA over the past 17 years, most recently at $45.5 million for Q1 2026.

  • Quarterly EBITDA rose 94.18% to $45.5 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $145.0 million through Mar 2026, up 409.4% year-over-year, with the annual reading at $122.9 million for FY2025, 471.77% up from the prior year.
  • EBITDA was $45.5 million for Q1 2026 at Myr, up from $37.8 million in the prior quarter.
  • Over five years, EBITDA peaked at $45.5 million in Q1 2026 and troughed at -$16.4 million in Q2 2024.
  • The 5-year median for EBITDA is $23.3 million (2023), against an average of $21.2 million.
  • Year-over-year, EBITDA tumbled 167.38% in 2024 and then soared 297.3% in 2025.
  • A 5-year view of EBITDA shows it stood at $25.9 million in 2022, then grew by 3.58% to $26.8 million in 2023, then plummeted by 64.48% to $9.5 million in 2024, then soared by 297.3% to $37.8 million in 2025, then grew by 20.33% to $45.5 million in 2026.
  • Per Business Quant, the three most recent readings for MYRG's EBITDA are $45.5 million (Q1 2026), $37.8 million (Q4 2025), and $30.3 million (Q3 2025).